Statins and their effect on cognition

Abstract

Get full access to this article

View all access options for this article.

References

Statistics Canada. Prescription medication use by Canadians aged 6 to 79. June 2014. Available: www.statcan.gc.ca/pub/82-003-x/2014006/article/14032-eng.pdf (accessed July 7, 2014).

Food and Drug Administration. Important safety label changes to cholesterol-lowering statin drugs. 2012. Available: www.fda.gov/Drugs/DrugSafety/ucm293101.htm (accessed July 7, 2014).

Health Canada. Statins and memory loss. Canadian Adverse Reaction Newsletter; 2005. Available: http://hc-sc.gc.ca/dhp-mps/alt_formats/hpfb-dgpsa/pdf/medeff/carn-bcei_v15n4-eng.pdf (accessed July 8, 2014).

Rojas-Fernandez

Goldstein

Levey

. An assessment by the Statin Cognitive Safety Task Force: 2014 update. J Clin Lipidol 2014;8:S5-16.

Mungas

In-office mental status testing: a practical guide. Geriatrics 1991;46:54-66.

Dementia Collaborative Research Centres. Cognition assessment measures. Available: www.dementia-assessment.com.au/cognitive/index.html (accessed Feb. 2, 2015).

Rockwood

Fay

Gorman

. The clinical meaningfulness of ADAS-Cog changes in Alzheimer’s disease patients treated with donepezil in an open-label trial. BMC Neurol 2007;7:26.

Proust-Lima

Amieva

Dartigues

. Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies. Am J Epidemiol 2007;165:344-50.

Richardson

Schoen

French

. Statins and cognitive function: a systematic review. Ann Intern Med 2013;159:688-97.

10.

Higgins

Altman

Gotzsche

. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.

11.

Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale for assessing the quality of nonrandomised studies in meta-analyses. Available: www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed July 13, 2014).

12.

Swiger

Manalac

Blumenthal

. Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects. Mayo Clinic Proc 2013;88:1213-21.

13.

Macedo

Taylor

Cassas

. Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis. BMC Med 2014;12:51.

14.

McGough

Faraone

. Estimating the size of treatment effects: moving beyond p values. Psychiatry (Edgmont) 2009;6:21-9.

15.

Ott

Daiello

Dahabreh

. Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials. J Gen Intern Med 2015;30:348-358.

16.

Alzheimer Society Canada. A new way of looking at the impact of dementia in Canada. 2012. Available: www.alzheimer.ca/~/media/Files/national/Media-releases/asc_factsheet_new_data_09272012_en.pdf (accessed July 13, 2014).

17.

Kandiah

Feldman

. Therapeutic potential of statins in Alzheimer’s disease. J Neurol Sci 2009;283:230-4.

18.

National Stroke Association. Vascular dementia. 2012. Available: www.stroke.org/we-can-help/survivors/stroke-recovery/post-stroke-conditions/cognition/vascular-dementia (accessed December 5, 2014).

19.

McGuinness

Craig

Bullock

. The Cochrane collaboration: statins for the prevention of dementia (review). Cochrane Library 2009;2:1-31.

20.

McGuinness

Craig

Bullock

. The Cochrane collaboration: statins for the treatment of dementia (review). Cochrane Library 2014;7:1-77.